InSite Releases Positive Results For Phase 3 Trial Of BromSite

Monday, December 23, 2013

Comments

Ocular Surgery News

InSite Vision announced top-line results from its confirmatory phase 3 clinical trial of BromSite for the reduction of inflammation and pain after cataract surgery, according to a press release.

Full Story

Management of corneal edema secondary to endothelial dysfunction can include the below EXCEPT:
1. Hypertonic saline drops
2. Endothelial transplantation (DSEK/DSAEK)
3. Full thickness penetrating keratoplasty (PKP)
4. Anterior lamellar transplantation (ALK)
Check The Answer

CareCloud Central
CareCloud Central is a medical practice ... view product
Selecta Trio™ YAG Laser, SLT and Photocoagulation
The Lumenis Selecta® Trio™ ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

InSite Releases Positive Results For Phase 3 Trial Of BromSite

Comments

Quick Quiz

Management of corneal edema secondary to endothelial dysfunction can include the below EXCEPT:

AdGlare RMR Ad

Featured Products

CareCloud Central

Selecta Trio™ YAG Laser, SLT and Photocoagulation

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us